Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Daiichi Sankyo
Cantor Fitzgerald
Harvard Business School
Julphar
Mallinckrodt
Cipla
Medtronic

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203364

« Back to Dashboard

NDA 203364 describes MESNA, which is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Mylan Institutional, Mylan Labs Ltd, Sagent Pharms, Teva Pharms Usa, and West-ward Pharms Int, and is included in seven NDAs. It is available from six suppliers. Additional details are available on the MESNA profile page.

The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mesna profile page.
Summary for 203364
Tradename:MESNA
Applicant:Mylan Labs Ltd
Ingredient:mesna
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 203364

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAVENOUSStrength100MG/ML
Approval Date:Jul 18, 2014TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Moodys
Accenture
Julphar
Fuji
Citi
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.